Skip to main content
Springer logoLink to Springer
. 2017 Oct 11;53(4):576–577. doi: 10.1007/s00535-017-1392-4

Erratum to: Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma

Wenhui Wang 1,, Qiuwei Pan 1, Gwenny M Fuhler 1, Ron Smits 1, Maikel P Peppelenbosch 1
PMCID: PMC6828004  PMID: 29022044

Erratum to: J Gastroenterol (2017) 52:419–431 DOI 10.1007/s00535-016-1299-5

In the original publication of the article, the frequency of loss-of-function mutations in AXIN1, AXIN2 and APC was underestimated in Table 1. The correct frequencies of these mutations in HCC are 10.4, 3.3, and 1.4%, respectively (in the following page).

Table 1.

Genetic mutation in components of Wnt/β-catenin pathway in HCC

References Patients Mutant samples Region
CTNNB1 AXIN1 AXIN2 APC
Rebouissou et al. [39] 373 146 (39%) NA NA NA France, Spain, Italy
Hirotsu et al. [40] 9 2 (22.2%) NA NA NA Japan
Schulze et al. [41] 243 95 (37.4%) 27 (11.1%) 3 (1.2%) 4 (1.6%) France, Italy, Spain
Kan et al. [42] 88 14 (15.9%) 4 (4.5%) 2 (2.3%) 2 (2.3%) China
Kitao et al. [43] 134 27 (20.1%) NA NA NA Japan
Ding et al. [44] 156 15 (9.6%) NA NA NA China
Tornesello et al. [45] 67 10 (14.9%) NA NA NA Southern Italy
Cleary et al. [46] 87 20 (22.9%) NA NA NA Canada, NC
Guichard et al. [47] 125 41 (32.8%) 19 (15.2%) NA 2 (1.6%) France
Lachenmayer et al. [48] 90 29 (32.2%) NA NA NA USA, Netherlands, Italy, Spain, Germany
Li et al. [49] 139 28 (20.1%) NA NA NA USA, Netherlands, China
Cieply et al. [50] 32 9 (28.1%) NA NA NA USA
Bengochea et al. [38] 62 16 (25.8%) NA NA NA Thailand, France
Austinat et al. [51] 40 10 (25%) 2 (5%) NA NA Germany
Kim et al. [52] 36 1 (2.8%) 9 (25%) NA NA Korea
Zucman-Rossi et al. [53] 45 18 (40%) 5 (11.1%) NA NA France
Boyault et al. [54] 120 34 (28.3%) 13 (10.8%) NA NA France
Zucman-Rossi et al. [55] 96 12 (12.5%) NA NA NA France
Park et al. [56] 81 13 (16%) 5 (6.2%) NA NA Korea
Ishizaki et al. [57] 89 10 (11.2%) 13 (14.6%) 9 (10.1%) NA Japan
Cui et al. [58] 34 15 (44.1%) NA NA NA China
Edamoto et al. [59] 100 24 (24%) NA NA 0 Japan, Switzerland
Taniguchi et al. [60] 73 14 (19.2%) 7 (9.6%) 2 (2.7%) NA UK
Wong et al. [61] 60 7 (11.7%) NA NA NA China
Mao et al. [62] 262 37 (14.1%) NA NA NA Taiwan
Cui et al. [63] 34 15 (44.1%) NA NA NA China
Laurent-Puig et al. [64] 137 26 (19%) 12 (8.8%) NA NA France
Devereux et al. [65] 62 5 (8.1%) NA NA NA China
Hsu et al. [66] 434 57 (13.1%) NA NA NA Taiwan
Satoh et al. [67] 87 0 (0%) 5 (5.7%) NA NA Japan
Huang et al. [68] 22 9 (41%) NA NA NA Japan, Switzerland
Legoix et al. [69] 119 21 (17.6%) NA NA NA France
Terris et al. [70] 73 14 (19.2%) NA NA NA France
Kondo et al. [71] 38 9 (24%) NA NA NA Japan
Nhieu et al. [72] 35 12 (34.3%) NA NA NA France
Miyoshi et al. [73] 75 14 (18.7%) NA NA NA Japan
de La Coste et al. [74] 31 8 (25.8%) NA NA NA France
Total 3788 837 (22.1%) 121 (10.4%) 16 (3.3%) 8 (1.4%)

NA not analyzed

On page 421, in the section of “Aberrant activation of Wnt/β-catenin signaling during HCC”, the sentence following “Missense, insertion, or partial deletions within CTNNB1 exon 3 lead to … stabilization of β-catenin in the cytoplasm” should be read as “Less frequently, loss-of-function mutation of AXIN1, AXIN2, or APC is found in 10.4, 3.3, and 1.4% of HCCs respectively…”.

Footnotes

The online version of the original article can be found under doi:10.1007/s00535-016-1299-5.

Contributor Information

Wenhui Wang, Phone: +31(0)107035145, Email: w.wang.1@erasmusmc.nl.

Maikel P. Peppelenbosch, Email: m.peppelenbosch@erasmusmc.nl


Articles from Journal of Gastroenterology are provided here courtesy of Springer

RESOURCES